another name for semaglutide injection New Weight Loss Medication Wegovy™ Approved by the FDA SkinnyRx: Injectable Semaglutide (GLP-1)

Key Shifts Ahead: Market Disruption: India, China, and other biosimilar hubs are driving the first wave of affordable semaglutide alternatives

The problem is obesity is categorised per BMI which is based on weight but by definition obesity is about excess adiposity and not weight

No measuring

Appetite suppression and craving reduction starts shortly after beginning the medication

Currently available biomarkers do not outperform serum ALT in identifying patients with NASH, which has poor sensitivity ( 3) and any amount of fibrosis, focus has shifted toward trials with fibrosis as the primary indicator of efficacy, as fibrosis is the histologic feature of NASH most clearly linked to risk of decompensation or liver-related events

It is delivered as a subcutaneous injection once a week